<?xml version="1.0" encoding="UTF-8"?>
<p id="p0110">Because of the safety issues surrounding the SNS LAV in ruminants, newer candidates have been developed, as described below. The goal of new vaccines has been to improve the safety profile, while retaining the advantages of LAVs (single dose, rapid onset of protection, and durability of immunity).</p>
